PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer

被引：0
|
作者：
Ambrosini, Francesca [1 ,2 ]
Koehler, Daniel [3 ]
Ghadban, Tarik [4 ]
Jacobsen, Frank [5 ]
Knipper, Sophie [1 ]
von Amsberg, Gunhild [1 ,6 ]
Steuber, Thomas [1 ,7 ]
Maurer, Tobias [1 ,7 ]
机构：
[1] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, 52 Martinistr, D-20246 Hamburg, Germany
[2] IRCCS Osped Policlin San Martino, Genoa, Italy
[3] Univ Hosp Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany
[4] Univ Hosp Hamburg Eppendorf, Dept Surg, Hamburg, Germany
[5] Univ Hosp Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[6] Univ Hosp Hamburg Eppendorf, Dept Oncol, Hamburg, Germany
[7] Univ Hosp Hamburg Eppendorf, Dept Urol, Hamburg, Germany
来源：
CENTRAL EUROPEAN JOURNAL OF UROLOGY | 2023年 / 76卷 / 03期
关键词：
prostate cancer; prostate-specific membrane antigen; liver; radioguided surgery;
D O I：
10.5173/ceju.2023.69
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We present the case of a patient who underwent an open radical prostatectomy with pelvic lymph node dissection (Gleason 4+3, pT3a pN1 R0) in March 2017. In November 2020, prostate-specific membrane antigen (PSMA) -radioguided salvage lymph node dissection was planned due to a single left para-rectal lymph node at a [68Ga] Ga-PSMA-I&T PET. In January 2022, the [68Ga] Ga-PSMA-I&T PET showed an isolated liver lesion. Biopsy confirmed prostate adenocarcinoma. A liver segmentectomy was performed. A complete biochemical response was reported until the last follow-up (December 2022). Prostate-specific membrane antigen positron emission tomography (PSMA PET)-directed metastasis-directed therapy may be an effective treatment in selected cases, allowing a benefit in the oncological outcome.
引用
收藏
页码：182 / 185
页数：4
相关论文
共 50 条
  • [21] Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP)
    Ost, P.
    Reynders, D.
    Decaestecker, K.
    Fonteyne, V.
    Lumen, N.
    De Bruycker, A.
    Lambert, B.
    Delrue, L.
    Bultijnck, R.
    Goetghebeur, E.
    Villeirs, G.
    De Man, K.
    Ameye, F.
    Billiet, I.
    Joniau, S.
    Vanhaverbeke, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S200 - S201
  • [22] Metastasis-directed therapy in testicular cancer
    Pandit, Kshitij
    Yuen, Kit
    Puri, Dhruv
    Yodkhunnatham, Nuphat
    Millard, Frederick
    Bagrodia, Aditya
    CURRENT OPINION IN UROLOGY, 2024, 34 (04) : 281 - 285
  • [23] Metastasis-Directed Therapy influence in clinical outcomes of oligorrecurrent prostate cancer
    Gonzalez Lopez, A.
    Buchser, D.
    Suarez, F.
    Mayrata, E.
    Casquero, F.
    Bilbao, P.
    Gomez-Iturriaga, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S621 - S622
  • [24] Patterns of Recurrence After Metastasis-Directed Therapy in Oligometastatic Prostate Cancer
    Onal, Cem
    Guler, Ozan Cem
    Oymak, Ezgi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05):
  • [25] Early biochemical response following PSMA PET-directed salvage nodal irradiation for prostate cancer
    Wake, J.
    Hayden, A.
    Do, V.
    Turner, S.
    Gebski, V.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S850 - S850
  • [26] THE ROLE OF METASTASIS-DIRECTED THERAPY IN THE JOURNEY OFOLIGOMETASTATIC PROSTATE CANCER PATIENTS
    Mastroleo, Federico
    Villa, Riccardo
    Colombi, Lorenzo
    Milovanova, Ekaterina
    Zamboglou, Costantinos
    Luzzago, Stefano
    Mistretta, Francesco Alessandro
    Alessi, Sarah
    Petralia, Giuseppe
    Carrafiello, Gianpaolo
    Musi, Gennaro
    De Cobelli, Ottavio
    Vincini, Maria Giulia
    Zaffaroni, Mattia
    Franco, Pierfrancesco
    Marvaso, Giulia
    Jereczek-Fossa, Barbara Alicja
    ANTICANCER RESEARCH, 2024, 44 (10)
  • [27] Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Not All That Glitters Is Gold
    Briganti, Alberto
    Gandaglia, Giorgio
    Montorsi, Francesco
    JAMA ONCOLOGY, 2020, 6 (10) : 1638 - 1639
  • [28] Oligorecurrent prostate cancer treated with metastasis-directed therapy: oncological outcomes
    Devos, G.
    Berghen, C.
    Joniau, S.
    Poels, K.
    Haustermans, K.
    Rans, K.
    De Meerleer, G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S633 - S633
  • [29] Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center
    Mueller, Peter J.
    Dietlein, Markus
    Kobe, Carsten
    Heidenreich, Axel
    Drzezga, Alexander
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (04): : 314 - 324
  • [30] Is there a role for metastasis-directed therapy in bladder cancer?
    Abufaraj, Mohammad
    Al Karmi, Joud
    Bdeir, Adan
    CURRENT OPINION IN UROLOGY, 2024, 34 (04) : 273 - 280
12345